Chandrashekhar D. Kamat

Author

University of Oklahoma Health Sciences Center

Also Known As

C. D. Kamat, C. Kamat, Chaitanya Kamat, Chandrashekhar D. Kamat, Chandrashekhar D Kamat, Chandrashekhar D. Kamat, Chandrashekhar Kamat, Chandrashekhar D. Kamat

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Oklahoma Health Sciences Center University of Warwick Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center University of Oklahoma

About

Chandrashekhar D. Kamat is an author at University of Oklahoma Health Sciences Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1K
2	Engineering	2	2	102
3	Biochemistry	2	2	34
4	Health Sciences	1	1	14
5	Public Health	1	1	58

Chandrashekhar D. Kamat

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat, Cancer Cell Oncogenic AgentMedicineEpigenetic ChangePharmacologyLsd1 Inhibitors	2015	498
Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling Michael A. Ihnat, Jessica E. Thorpe, Chandrashekhar D. Kamat, Diabetologia Redox SignalingSignal TransductionCell SignalingMedicinePhysiology	2007	217
Role of HIF Signaling on Tumorigenesis in Response to Chronic Low-Dose Arsenic Administration Chandrashekhar D. Kamat, Dixy E. Green, Susan Curilla, Toxicological Sciences Chemoprevention StrategyCancer BiologyTumor BiologyDrinking WaterTrivalent Inorganic Arsenic	2005	73
A survey of sesamin and composition of tocopherol variability from seeds of eleven diverse sesame (<i>Sesamum indicum</i> L.) genotypes using HPLC‐PAD‐ECD Kelly S. Williamson, J. B. Morris, Quentin N. Pye, Phytochemical Analysis Plant AnalysisEngineeringBotanyAgricultural EconomicsCrop Improvement	2007	58
Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia Chandrashekhar D. Kamat, Dixy E. Green, Linda A. Warnke, Cancer Letters Mutant P53Tumor BiologyAngiogenesisHyperproliferative PhenotypeRedox Regulator	2006	54
Poly(β-amino ester) Nanoparticle Delivery of <i>TP53</i> Has Activity against Small Cell Lung Cancer <i>In Vitro</i> and <i>In Vivo</i> Chandrashekhar D. Kamat, Ron B. Shmueli, Nick Connis, Molecular Cancer Therapeutics NanotherapeuticsEngineeringNanoparticle Deliveryβ-Amino EsterTp53 Delivery	2013	44
Structure–activity relationships studies of the anti-angiogenic activities of linomide Jiandong Shi, Zili Xiao, Michael A. Ihnat, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryMedicineVascular PharmacologyCardiovascular Pharmacology	2003	40
Attenuated Superoxide Dismutase Induction in Retinal Cells in Response to Intermittent High Versus Continuous High Glucose Michael A. Ihnat, Ronald C. Kaltreider, Jessica E. Thorpe, American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology Ocular DiseaseHigh GlucoseRedox BiologyOxidative StressRetinal Cells	2007	20
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia Bhagwat Gunale, Nicholas Farinola, Chandrashekhar D. Kamat, The Lancet Infectious Diseases VaccinationVector-borne PathogenDose StudyPhase 1Vector Control	2024	20
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial Prasad S. Kulkarni, Anirudha Vyankatesh Potey, Sandesh Bharati, The Lancet VaccinationVaccine SafetyCross-protectionTyphoid FeverPathogenesis	2024	19

Page 1